Katie Darius

Katie Darius has a diverse work experience spanning several companies and industries. Katie is currently serving as the VP of Program Governance & Portfolio Management at Entrada Therapeutics since June 2021. Prior to that, they worked at Pfizer from 2018 to 2021, where they held the positions of Senior Director of Oncology Early Commercial Development and Senior Director of Oncology New Business Assessment.

Before joining Pfizer, Katie was the Head of Academic Networks at Flatiron Health from 2016 to 2017. Katie also served as a Senior Director in the Life Sciences division of Huron Consulting Group from 2014 to 2016, following the acquisition of Frankel Group, where they worked as a Principal from 2010 to 2014.

Earlier in their career, Katie worked as a Consultant at Sg2 from 2008 to 2009. Katie began their professional journey as a Research Fellow at the National Institutes of Health from 2000 to 2002.

Katie Darius has a Bachelor of Science degree in Biomedical Engineering from Northwestern University. Katie also holds a PhD in Bioengineering from the University of Pennsylvania. However, the specific start and end years for their education are unknown.